Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Expert Opinion on Investigational Drugs
|
August 23, 2013
Current phase II clinical data for ridaforolimus in cancer
Anna Spreafico, Helen J Mackay
Cancer
|
September 15, 2020
Intraperitoneal chemotherapy: Hot, timely, and relevant?
Helen J Mackay, Elise C Kohn
Nature Reviews. Cancer
|
June 23, 2007
Targeting the protein kinase C family: are we there yet?
Helen J Mackay, Christopher J Twelves
Journal of Oncology Practice
|
November 19, 2016
Ovarian Sex Cord-Stromal Tumors: The Challenge of Rare Gynecologic Malignancies
Katarzyna J Jerzak, Helen J MacKay
Gynecologic Oncology Research and Practice
|
May 28, 2016
Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future
Victor Rodriguez-Freixinos, Helen J Mackay
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Other new targets
Helen J Mackay, Amit M Oza
Journal of Oncology
|
January 6, 2010
The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
Lilian T Gien, Helen J Mackay
Expert Opinion on Investigational Drugs
|
April 11, 2014
Recent and current Phase II clinical trials in endometrial cancer: review of the state of art
Stephanie Lheureux, Michelle Wilson, Helen J Mackay
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond
Helen J Mackay, Lari Wenzel, Linda Mileshkin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer
Charlie Gourley, Joan L Walker, Helen J Mackay
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Expert Opinion on Investigational Drugs
|
August 23, 2013
Current phase II clinical data for ridaforolimus in cancer
Anna Spreafico, Helen J Mackay
Cancer
|
September 15, 2020
Intraperitoneal chemotherapy: Hot, timely, and relevant?
Helen J Mackay, Elise C Kohn
Nature Reviews. Cancer
|
June 23, 2007
Targeting the protein kinase C family: are we there yet?
Helen J Mackay, Christopher J Twelves
Journal of Oncology Practice
|
November 19, 2016
Ovarian Sex Cord-Stromal Tumors: The Challenge of Rare Gynecologic Malignancies
Katarzyna J Jerzak, Helen J MacKay
Gynecologic Oncology Research and Practice
|
May 28, 2016
Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future
Victor Rodriguez-Freixinos, Helen J Mackay
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Other new targets
Helen J Mackay, Amit M Oza
Journal of Oncology
|
January 6, 2010
The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
Lilian T Gien, Helen J Mackay
Expert Opinion on Investigational Drugs
|
April 11, 2014
Recent and current Phase II clinical trials in endometrial cancer: review of the state of art
Stephanie Lheureux, Michelle Wilson, Helen J Mackay
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond
Helen J Mackay, Lari Wenzel, Linda Mileshkin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer
Charlie Gourley, Joan L Walker, Helen J Mackay
Page
of 6